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 Introduction 
 Th is is an exciting time for researchers working to improve health 
care and health care delivery. Innovations in medical and surgical 
practice have led to a greater diversity in therapeutic approaches for 
many diseases. Although clinical trials are invaluable in assessing 
treatment effi  cacy, they oft en do not address important issues 
such as applicability, cost, or the ease of implementation for real-
world health care practice. Until very recently, there has been 
limited evidence about the comparative eff ectiveness of medical 
interventions to help patients and health care practitioners make 
decisions. 1–4 However, impelled by rising health care costs, the 
increasing number of diagnostic and therapeutic options available, 
evidence of variation in spending without benefi t, and recent health 
care reform legislation, comparative eff ectiveness research (CER) 
for patient-centered outcomes research has been recognized as 
essential for sustainable health care delivery in the United States. 
In this paper, we adopt the defi nition of CER as described by 
the US Department of Health and Human Services Federal 
Coordinating Council at  http://www.hhs.gov/recovery/programs/
cer/execsummary.html : “Comparative eff ectiveness research is the 
conduct and synthesis of research comparing the benefi ts and harms 
of diff erent interventions and strategies to prevent, diagnose, treat 
and monitor health conditions in “real world” settings. Th e purpose 
of this research is to improve health outcomes by developing and 
disseminating evidence based information to patients, clinicians, 
and other decision makers, responding to their expressed needs, 
about which interventions are most eff ective for which patients 
under specifi c circumstances.”  5–11 
 A well-trained workforce is essential to identify pressing CER 
questions, design and conduct rigorous studies to answer these 
questions, and facilitate the implementation of research fi ndings 
into real-world practices and policies. All of these activities are 
driven by the needs of patients, clinicians, researchers, as well as 
other stakeholders and decision makers who are vital partners in 
this research. To be successful, these vital partners must include 
representatives from the general public, health care entities, 
formulary committee members, payors, policy makers, industry, 
regulators, research reviewers and funders, and government. It 
is especially relevant to note the CER is a broad concept with 
the prospects of infl uencing prevention, diagnosis, treatments, 
and even the delivery of health care. Given the breadth of CER 
and its imminent importance to health care improvement and 
cost management, academic health programs need to consider 
the general competencies needed for those within and outside 
of the CER workforce. 
 Academic medical centers, especially institutions receiving 
support from the National Institutes of Health (NIH) Clinical 
and Translational Science Awards (CTSA), are well positioned 
to be leaders in training investigators, conducting CER, and 
disseminating results into real-world practices and policies. 
Th e CTSA Key Function Committee on CER was established to 
advance CER and facilitate communication and collaboration of 
activities across the CTSA consortium. Th is Committee established 
the CER Workgroup on Education, Training, and Workforce 
Development. The Workgroup members and collaborators 
identifi ed the need to delineate the specifi c competencies that are 
fundamental to practitioners and users of CER. In this preliminary 
CER competencies paper, we incorporated conceptual themes 
from the 2010 CTSA CER White Papers on facilitating CER 
and CER workforce development. 12,13 We describe our initial 
assessment of the workforce who will conduct, disseminate, and 
use the results of CER and the competencies that they will need 
to acquire to conduct CER. By developing these preliminary CER 
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 Abstract 
 The Clinical and Translational Science Award (CTSA) Workgroup for Comparative Effectiveness Research (CER) Education, Training, 
and Workforce Development identifi ed a need to delineate the competencies that practitioners and users of CER for patient-centered 
outcomes research, should acquire. With input from CTSA representatives and collaborators, we began by describing the workforce. We 
recognize the workforce that conducts CER and the end users who use CER to improve the health of individuals and communities. We 
generated a preliminary set of competencies and solicited feedback from the CER representatives at each member site of the CTSA 
consortium. We distinguished  applied competencies (i.e., skills needed by individuals who conduct CER) from  foundational competencies 
that are needed by the entire CER workforce, including end users of CER. Key competency categories of relevance to both practitioners 
and users of CER were: (1) asking relevant research questions; (2) recognizing or designing ideal CER studies; (3) executing or using 
CER studies; (4) using appropriate statistical analyses for CER; and (5) communicating and disseminating CER study results to improve 
health. Although CER is particularly broad concept, we anticipate that these preliminary, relatively generic competencies will be used in 
tailoring curricula to individual learners from a variety of programmatic perspectives. Clin Trans Sci 2012; Volume 5: 476–479
 Keywords:  comparative effectiveness research ,  competencies ,  work force 
476 VOLUME 5 • ISSUE 6 WWW.CTSJOURNAL.COM
477VOLUME 5 • ISSUE 6WWW.CTSJOURNAL.COM
Segal et al. ■ Comparative Effectiveness Research Competencies
competencies, we aim to improve the health of individuals and 
communities through patient-centered outcomes research. 
 Workforce 
 Ann Bonham of the American Association of Medical Colleges 
(AAMC) and colleagues wrote a commentary describing a new 
agenda for research that may emerge from the health care reform 
legislation. 14 Th ey observed that the legislation has led to an 
increased emphasis on implementation of the results of research. 
Th is science of implementation requires knowledge of human and 
organizational behaviors, skills in educating health professionals, 
knowledge of health care fi nancing, skills of assessing patient 
and individual preferences, and familiarity with quality 
improvement methodologies. Th e authors encourage academic 
health centers to revisit their research missions and forge new 
partnerships “with [colleagues in the] economic, behavioral, 
anthropological, and managerial sciences, building not only on 
the skills of clinical epidemiologists and health economists but 
also those of decision scientists, health care educators, operations 
researchers, systems engineers, information technologists, 
behavioral psychologists, health services researchers, and other 
scholars.” Th ey urge to strengthened ties with colleagues in 
pharmacy, nursing, and social work as well as administrative 
and community partners. Jonas and Crotty also observed that 
participants in CER come from diverse backgrounds including 
clinical medicine, pharmacology, epidemiology, biostatistics, 
public health, informatics, health policy, library science, health 
economics, and others. Th ey suggested that it will be “challenging 
to provide the training necessary to standardize CER methods 
when those involved come from diverse fi elds using diverse 
terminology.” 15 
 Given this view of an expanded workforce that includes 
individuals with diverse skills, we address the workforce needed 
for CER activities. Th rough a series of conference calls and email 
exchanges, we began by classifying groups of individuals as being 
 within the CER workforce (i.e., practitioners directly involved in 
conducting CER), and as being  outside of the workforce (i.e., end 
user stakeholders) along the pathway from knowledge discovery 
to improving health outcomes. Th ese end user stakeholders may 
be patients and clinicians, as well as the general public, health 
care entities, formulary committee members, payors, policy 
makers, industry, regulators, research reviewers and funders, 
and government.  Figure 1 depicts the workforce linearly with 
knowledge “moving” from left  to right with information fl ows 
in bidirectionally. Ideally, the results of a given research study 
will, with input from end user stakeholders, inform the next CER 
projects that have the greatest potential for improving health. 
 As shown in  Figure 1 , individuals who are members of the CER 
workforce include: (1)  Investigators with diverse backgrounds 
who design, support, and implement CER studies; (2)  Technical 
staff  (including project managers, research 
nurses, analysts, and research assistants) who 
execute CER studies; and (3)  Knowledge 
translators who take the results of CER to 
the end user stakeholders. Th ese knowledge 
translators may include the media, advocacy 
groups, patient educators, and knowledge 
translation researchers. CER investigators 
may also be included among the knowledge 
translators. 
 Individuals who are outside the CER 
workforce but who are on the translational pathway from discovery 
to health are: (1)  Early-phase researchers who conduct research 
that is earlier on the translational pathway than CER; (2)  Patients 
and clinicians who participate in studies that generate comparative 
eff ectiveness knowledge; and (3) other  Stakeholders and decision 
makers who may reap the patient-centered outcomes research 
benefi ts from implementing the fi ndings of CER. Th ese other 
stakeholders may include the general public, health care entities, 
formulary committee members, payors, policy makers, industry, 
regulators, research reviewers and funders, and government. 
 We off er this framework to identify the competencies that 
may be needed by practitioners within the CER workforce and 
end users outside of the CER workforce. 
 Competencies 
 Competencies are the knowledge and skills that individuals need 
to perform their work well. Competencies are ideally stated in 
behavioral terms and framed as something that is measurable. 16 
 We reviewed the list of 10 broad competencies for clinical 
and translational research that were developed for the CTSA 
consortium. Using this list, we generated CER-specifi c competencies 
within each of these 10 categories. We generated 40 preliminary 
competencies that we shared with the CER representatives at each 
of the 55 CTSAs that existed at that time. Th e representatives were 
the individuals identifi ed by the CTSA Principal Investigators 
as being most conversant in CER. We asked representatives to 
rank how  essential (on a 5-point scale) each competency was to 
an investigator who conducts CER. We had 21 respondents; if 
 fewer than 60% responded that the competency was essential or 
highly essential, it was eliminated from further consideration. As 
we were collecting these responses, we reviewed recent products 
from other organizations generating related competency criteria, 
including the International Society for Pharmacoepidemiology 
and the Pharmaceutical Manufacturers Association (PhRMA) 
Foundation. 17 We also reviewed the competencies generated 
by the Key Function Committees (KFC) for Education and 
for Community Engagement in the CTSA consortium as they 
have complementary interests to the CER KFC. We employed 
the grades assigned by the CER representatives to prioritize the 
competencies that would be retained in the fi nal set. 
 As we developed the competencies, we considered to whom 
they might apply and we defined two distinct competency 
levels: foundational and applied. In general, the competencies 
at a foundational level should be required of all investigators 
engaged in CER as well as all individuals who use the results 
of CER. Th e applied level competencies are required of the 
investigative team conducting CER. With the input of the CTSA 
CER representatives and collaborators through feedback at the 
NIH CTSA CER Stakeholder Forums in May and December 2010, 
CER competency preparation meetings, and from investigators in 
 Figure 1.  Groups of individuals who may benefi t from acquiring competency in the skills of CER. Dark boxes 
represent individuals within the CER workforce; light boxes represent individuals outside of the CER workforce 
but within the translational pathway. 
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the Centers for Education and Research on Th erapeutics (CERTs) 
program of the Agency for Healthcare Research and Quality, 
we trimmed the initial 40 competencies to 30 competencies 
(10 foundational and 20 applied) and categorized them in fi ve 
domains paralleling the domains of clinical and translational 
research competencies as endorsed by the CTSA consortium. We 
Foundational level Applied level
Asks relevant research questions
•Formulates questions that will inform an end user stakeholder or 
decision maker about the relative effectiveness, safety, or costs of 
two or more interventions.
•Identifi es the breadth of decision makers who would benefi t from 
the results of CER and demonstrates ability to engage them in the 
development of relevant research questions.
•Seeks and identifi es strong evidence for decision making based on 
evidence-based medicine and patient relevant outcomes research.
•Phrases questions about health care delivery as key questions for 
comparative effectiveness research.
•Phrases questions about prevention, screening, and diagnosis, in 
addition to treatment, as appropriate questions for CER.
Recognizes or designs ideal CER studies
•Describes the difference between effi cacy and effectiveness studies. •Identifi es and designs studies using a noninferiority design.
•Identifi es approaches to optimize the design and use of 
 observational studies for CER.
•Describes key features of a systematic review of the literature. •Explains the role of registries in CER and is able to design a registry.
•Identifi es primary sources of high quality systematic reviews 
and meta-analyses.
•Explains key features of pragmatic trial design and is able to 
 design a pragmatic trial
•Describes patient-relevant outcomes. •Designs studies that evaluate test performance along the 
 continuum from analytic validity to clinical validity to clinical 
utility with patient-relevant outcomes.
•Conducts a systematic review of the literature and/or meta-
 analysis with appropriate methodology.
•Design studies that account for underrepresentation of minority 
populations in existing data sources.
•Identifi es and/or designs valid tools for measuring patient-
 reported outcomes.
Executes or uses CER studies
•Demonstrates appropriate human subjects protection including 
privacy protection in comparative effectiveness research.
•Demonstrates ability to write a research proposal incorporating 
the important elements of CER.
•Identifi es key results and important limitations in a 
comparative effectiveness study.
•Demonstrates ability to assess patient relevant outcomes, using 
appropriate and culturally appropriate instruments or tools.
•Identifi es sources of existing data for observational research 
 including electronic health records and administrative claims.
•States the strengths and limitations of different data and the 
sources of bias and threats to internal validity in each.
Uses appropriate statistical analyses for CER
•Identifi es the strengths and limitations of the different 
statistical methodologies used in CER.
•Applies methods to minimize threats to internal validity of studies 
such as in secondary data analyses.
•Applies appropriate methods for meta-analysis and/or 
 meta-regression.
•Describes concept of heterogeneity of treatment effect 
(treatment response heterogeneity) and uses appropriate 
methods for exploration.
•Applies appropriate covariate balancing methods as needed in 
observational research.
Communicates and disseminates study results to allow for implementation of the results of research
•Communicates results of research to peer group. •Prepares results in formats appropriate for the end user 
 stakeholders who will make decisions with results.
•Identifi es methods of dissemination of results that reach the end 
user stakeholders who will benefi t from the results.
•Identifi es remaining evidence needs and gaps and communicates 
them to appropriate decision makers.
CER = Comparative effectiveness research.
 Table 1.  Foundational and applied competencies for comparative effectiveness research. 
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also sought input from the Agency for Healthcare Research and 
Quality Evidence Based Practice researchers ( Table 1 ). 
 Next Steps 
 We recognize the broad interests that diff erent organizations 
have in curriculum development on the topic of CER. We do not 
presume that these are the defi nitive competencies, as diff erent 
groups of trainees will likely have specialized needs that may 
not be captured in these competencies. We suggest, however, 
that this set may be a useful starting point for organizations 
that are developing competencies and the curricula to impart 
the necessary knowledge and skill set. Similarly, not every CER 
investigator will have applied expertise in all competency areas. 
For examples, investigators in systematic review should certainly 
have foundational expertise in issues of study design, but may 
not have applied expertise in the conduct of secondary data 
analyses. 
 Th ese preliminary competencies are written at a fairly high 
level so that they would be fl exible across settings from master’s 
level students in an introductory CER course to bench scientists 
advancing their translational skills. Meeting their diverse needs 
requires specialized curricula but the competency goals should 
be comparable. 
 Needed now is a process of vetting of these competencies 
by the organizations involved in training, which may well 
involve modifying those provided in  Table 1 . We hope that these 
preliminary competencies are considered as the CER workforce 
further develops and as CER is used to build evidence-based 
decision making more broadly toward improving patient-
centered outcomes. 
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